. "1 Introduction." Informing America's Policy on Illegal Drugs: What We Don't Know Keeps Hurting Us. Washington, DC: The National Academies Press, 2001.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Informing America’s Policy on Illegal Drugs: What We Don’t Know Keeps Hurting Us
Treatment of Drug Users: Chapter 8
The committee recommends that priorities for the funding of treatment evaluation research should be changed; large-scale, national treatment inventory studies should not be conducted at the expense of greater funding for randomized controlled clinical trials.
249
NIDA
X
The committee recommends greater scientific attention to now-missed opportunities to conduct randomized trials of drug treatments with no-treatment control conditions.
258
NIDA
X
The committee recommends that treatment researchers take greater advantage of possible opportunities for randomization to no-treatment control groups. For example, we strongly encourage studies of incarcerated and postincarcerated prisoners as outlined in this report. The committee urges federal and state agencies and private institutions to minimize organizational obstacles to such studies, within ethical and legal bounds.
263
NIDA
X
The committee strongly recommends that treatments intended to benefit people be evaluated in carefully conducted randomized controlled experiments.
263
NIDA
X
The committee recommends broader use of meta-analytic techniques for cumulating and comparing findings across treatment outcome studies.
